Commercial Credit Report for Mega Lifesciences PCL

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Mega Lifesciences PCL is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Mega Lifesciences PCL
Floor 9 and 10, Ample Tower Building
120 Mu 11, Bangna-Trat Road
Phone: +66 27694222p:+66 27694222	BANGKOK, 10280 Thailand	Ticker: MEGAMEGA

Business Summary

Mega Lifesciences Public Company Limited is a Thailand-based company. The Company is engaged in manufacturing and selling through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins and fast-moving consumer goods, as well as the provision of distribution services relating to such products. Its segments include Brands, Distribution, and OEM (Original Equipment Manufacturer). The Brands segment represents a business segment in which goods are manufactured and sold under brands owned by the Company. The Distribution segment represents a service business segment in which the Company provides logistical and marketing services for goods trading purposes and the sale of goods manufactured by third parties. The OEM segment represents a business segment in which goods are manufactured by third parties under brands not owned by the Company.

(Source: F-4)

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
9/30/2024	12/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
2834	Pharmaceutical preparations
2833	Medicinal chemicals and botanical products
5122	Drugs, drug proprietaries, and druggists' sundries
5047	Medical, dental, and hospital equipment and supplies

Officers and Directors

Title	Name	Age	Title Date	Start Date
Independent Chairman of the Board	MechaiViravaidya	83	2/1/2013	2/1/2013
Chief Executive Officer, Executive Director	VivekDhawan	63	2/1/2013	2/1/2013
Independent Vice Chairman of the Board	Yim KamChi	67	4/5/2022	2/1/2013
9 additional Officers and Directors records available in full report.

General Information

Number of Employees:	5,513	(As of 12/31/2023)
Outstanding Shares:	871,869,508	(As of 9/30/2024)
Stock Exchange:	BAK
Fax Number:	+66 27694244

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN